Biotech Values

[swampboots]

One targeted therapy oncolytic virotherapy uses a virus that infects and breaks down only cancer cells
New money is still coming in as 114 current studies, and today:

https://endpts.com/can-an-oncolytic-virus-therapy-challenge-the-longstanding-standard-of-care-in-bladder-cancer-cg-oncology-has-120m-to-find-out/

And yet I personally conclude this therapy although on the cusp of major breakthroughs is not without major investment perils., but a good catch all 'meme" (OV's) to garner much needed additional research money.

In the building of an opinion considering the future success of OV's, this summation (about a year old) of the spectrum of recent developments comprising the current challenges of OV's, still required from additional contributions from the areas of molecular biology, structural biology, immunology, genomics, and bioinformatics, merits very complex attentions.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474975/#:~:text=The%20clinical%20use%20of%20oncolytic,in%20the%20patient's%20clinical%20condition.